本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ultragenyx Pharmaceutical Inc

13.07
-0.5400-3.97%
盤後13.100.0300+0.23%19:58 EDT
成交量:565.48萬
成交額:7,404.19萬
市值:12.85億
市盈率:-2.24
高:13.59
開:13.56
低:12.88
收:13.61
52周最高:39.89
52周最低:12.88
股本:9,831.72萬
流通股本:8,071.56萬
量比:1.21
換手率:7.01%
股息:- -
股息率:- -
每股收益(TTM):-5.8279
每股收益(LYR):-5.8316
淨資產收益率:-608.47%
總資產收益率:-24.22%
市淨率:-4.42
市盈率(LYR):-2.24

資料載入中...

2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/03

重要事件披露

Form 8-K - Current report
2026/08/19

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/31

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/31

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

重要事件披露

Form 8-K - Current report